Private Capital Group’s CONMED CNMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$32K Sell
331
-19
-5% -$2.28K 0.02% 628
2022
Q1
$52K Sell
350
-18
-5% -$2.51K 0.01% 630
2021
Q4
$52K Hold
368
0.01% 659
2021
Q3
$48K Buy
368
+270
+276% +$35.3K 0.01% 690
2021
Q2
$14K Buy
98
+22
+29% +$3.01K ﹤0.01% 1225
2021
Q1
$10K Sell
76
-142
-65% -$17.1K ﹤0.01% 1285
2020
Q4
$25K Buy
218
+9
+4% +$852 ﹤0.01% 1084
2020
Q3
$16K Buy
209
+3
+1% +$245 ﹤0.01% 1167
2020
Q2
$15K Buy
206
+84
+69% +$5.84K ﹤0.01% 1199
2020
Q1
$7K Sell
122
-293
-71% -$27K ﹤0.01% 1383
2019
Q4
$46K Sell
415
-3
-0.7% -$320 0.01% 774
2019
Q3
$40K Buy
+418
New +$39.2K 0.01% 869
2019
Q2
Sell
-65
Closed -$5K 2243
2019
Q1
$5K Buy
65
+7
+12% +$509 ﹤0.01% 1661
2018
Q4
$4K Buy
+58
New +$3.97K ﹤0.01% 1671

Other funds holding CNMD

Private Capital Group's CNMD Position: Q2 2022 in Review

Private Capital Group reduced its CONMED (CNMD) stake by 5.4% in Q2 2022, selling an estimated $2.28K and leaving 331 shares worth $32K. The position accounts for 0.02% of the portfolio, ranked #628.

Private Capital Group first reported a position in CNMD in Q4 2018 and has held it in 14 quarters since. The position peaked at $52K in Q1 2022. 280 funds tracked by Wall St. Rank hold CNMD as of Q2 2022.

  • Private Capital Group held 331 shares of CONMED worth $32K as of Q2 2022.
  • Private Capital Group sold 19 CONMED shares in Q2 2022, an estimated $2.28K.
  • CONMED made up 0.02% of Private Capital Group's portfolio in Q2 2022, its #628 holding.
  • Private Capital Group first reported a position in CONMED in Q4 2018 and has held it in 14 quarters since.
  • Private Capital Group's CONMED position peaked at $52K in Q1 2022.
  • 280 funds tracked by Wall St. Rank held CONMED as of Q2 2022.

Based on Private Capital Group's 13F filing for Q2 2022, filed 28 Jul 2022.